ID

24870

Beschreibung

S0100 INDUCTION AND CONSOLIDATION TOXICITY FORM Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=AEB46CC2-6DA8-4268-E034-0003BA12F5E7

Link

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=AEB46CC2-6DA8-4268-E034-0003BA12F5E7

Stichworte

  1. 19.09.12 19.09.12 -
  2. 21.08.17 21.08.17 -
Hochgeladen am

21. August 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0 Legacy

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Leukemia null Toxicity - S0100 INDUCTION AND CONSOLIDATION TOXICITY FORM - 2071052v3.0

Instructions: Please complete after each cycle of treatment. All dates are MONTH, DAY, YEAR. Explain any blank fields or blank dates in the Comments section. Place an X in appropriate boxes. Circle AMENDED items in red.

Toxicity
Beschreibung

Toxicity

Alias
UMLS CUI-1
C0013221
UMLS CUI-2
C0040539
UMLS CUI-3
C0023418
Were toxicities assessed for this treatment cycle?
Beschreibung

toxicities

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013221
UMLS CUI [1,2]
C0220825
Date of most recent toxicity assessment
Beschreibung

Date toxicity assessment

Datentyp

date

Alias
UMLS CUI [1,1]
C0013221
UMLS CUI [1,2]
C0220825
UMLS CUI [1,3]
C0011008
why were toxicities not assessed?
Beschreibung

whyweretoxicitiesnotassessed?

Datentyp

text

Alias
UMLS CUI [1,1]
C0013221
UMLS CUI [1,2]
C0220825
Code
Beschreibung

CTC Code

Datentyp

text

Alias
UMLS CUI [1,1]
C0805701
UMLS CUI [1,2]
C1516728
Toxicity
Beschreibung

CTC Adverse Event Term

Datentyp

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C1516728
Grade
Beschreibung

CTCAdverseEventGrade

Datentyp

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0441800
UMLS CUI [1,3]
C1516728
Treatment Relation
Beschreibung

CTCAdverseEventAttributionCode

Datentyp

integer

Alias
UMLS CUI [1,1]
C1706735
UMLS CUI [1,2]
C1516728
Notes
Beschreibung

Comment

Datentyp

text

Alias
UMLS CUI [1,1]
C0947611
UMLS CUI [1,2]
C1516728
Ccrr Module For S0100 Induction And Consolidation Toxicity Form
Beschreibung

Ccrr Module For S0100 Induction And Consolidation Toxicity Form

Alias
UMLS CUI-1
C0013221
UMLS CUI-2
C0087111
UMLS CUI-3
C0023418
SWOG Patient ID
Beschreibung

Patient ID

Datentyp

text

Alias
UMLS CUI [1]
C2348585
SWOG Study No.
Beschreibung

Study Number

Datentyp

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C0600091
Registration Step
Beschreibung

Registration Step

Datentyp

text

Alias
UMLS CUI-1
C1514821
Patient Initials
Beschreibung

Patient Initials

Datentyp

text

Alias
UMLS CUI [1]
C2986440
Institution/Affiliate
Beschreibung

Institution

Datentyp

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Physician
Beschreibung

Treating Physician

Datentyp

text

Alias
NCI Thesaurus Property
C25364
NCI Thesaurus ObjectClass
C25741
NCI Thesaurus ObjectClass-2
C25705
UMLS CUI [1]
C1710470
Cycle
Beschreibung

Cycle

Datentyp

integer

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0205390
UMLS CUI [2]
C0023418

Ähnliche Modelle

Instructions: Please complete after each cycle of treatment. All dates are MONTH, DAY, YEAR. Explain any blank fields or blank dates in the Comments section. Place an X in appropriate boxes. Circle AMENDED items in red.

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Toxicity
C0013221 (UMLS CUI-1)
C0040539 (UMLS CUI-2)
C0023418 (UMLS CUI-3)
toxicities
Item
Were toxicities assessed for this treatment cycle?
boolean
C0013221 (UMLS CUI [1,1])
C0220825 (UMLS CUI [1,2])
Date toxicity assessment
Item
Date of most recent toxicity assessment
date
C0013221 (UMLS CUI [1,1])
C0220825 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
whyweretoxicitiesnotassessed?
Item
why were toxicities not assessed?
text
C0013221 (UMLS CUI [1,1])
C0220825 (UMLS CUI [1,2])
CTC Code
Item
Code
text
C0805701 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Item
Toxicity
integer
C0877248 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Code List
Toxicity
CL Item
Cardiac left ventricular function (1)
(Comment:en)
CL Item
Cardiac ischemia/infarction (2)
(Comment:en)
CL Item
Hypertension (3)
(Comment:en)
CL Item
Hypotension (4)
(Comment:en)
CL Item
Conjunctivitis (5)
(Comment:en)
CL Item
Photophobia (6)
(Comment:en)
CL Item
Fever (7)
(Comment:en)
CL Item
Chills (8)
(Comment:en)
CL Item
Sweating (9)
(Comment:en)
CL Item
Fatigue/malaise/lethargy (10)
(Comment:en)
CL Item
Weight loss (11)
(Comment:en)
CL Item
Flushing (12)
(Comment:en)
CL Item
Nausea (13)
(Comment:en)
CL Item
Anorexia (14)
(Comment:en)
CL Item
Vomiting (15)
(Comment:en)
CL Item
Diarrhea (16)
(Comment:en)
CL Item
Dehydration (17)
(Comment:en)
CL Item
Constipation (18)
(Comment:en)
CL Item
Gastritis (19)
(Comment:en)
CL Item
Duodenal ulcer (20)
(Comment:en)
CL Item
Gastric ulcer (21)
(Comment:en)
CL Item
Stomatitis/pharyngitis (22)
(Comment:en)
CL Item
Pancreatitis (23)
(Comment:en)
CL Item
Creatinine increase (24)
(Comment:en)
CL Item
Renal failure (25)
(Comment:en)
CL Item
Hemorrhage (26)
(Comment:en)
CL Item
Hematuria (27)
(Comment:en)
CL Item
Melana/GI bleeding (28)
(Comment:en)
CL Item
Allergic reaction (29)
(Comment:en)
CL Item
Infection w/o neutropenia (30)
(Comment:en)
CL Item
Infection w/ neutropenia (31)
(Comment:en)
CL Item
Bilirubin increase (32)
(Comment:en)
CL Item
SGOT increase (33)
(Comment:en)
CL Item
SGPT increase (34)
(Comment:en)
CL Item
Pneumonitis/infiltrates (35)
(Comment:en)
CL Item
Cough (36)
(Comment:en)
CL Item
ARDS (37)
(Comment:en)
CL Item
Hypocalcemia (38)
(Comment:en)
CL Item
Hyperkalemia (39)
(Comment:en)
CL Item
Hyperglycemia (40)
(Comment:en)
CL Item
Hypercalcemia (41)
(Comment:en)
CL Item
Somnolence (42)
(Comment:en)
CL Item
Mood alteration-depression (43)
(Comment:en)
CL Item
Personality/ behavioral change (44)
(Comment:en)
CL Item
Seizures (45)
(Comment:en)
CL Item
Motor neuropathy (46)
(Comment:en)
CL Item
Sensory neuropathy (47)
(Comment:en)
CL Item
Speech impairment (48)
(Comment:en)
CL Item
Dizziness/lightheadedness (49)
(Comment:en)
CL Item
Headache (50)
(Comment:en)
CL Item
Bone pain (51)
(Comment:en)
CL Item
Myalgia (52)
(Comment:en)
CL Item
Arthralgia (53)
(Comment:en)
CL Item
Rash/desquamation (54)
(Comment:en)
CL Item
Urticaria (55)
(Comment:en)
CL Item
Pruritis (56)
(Comment:en)
CL Item
Photosensitivity (57)
(Comment:en)
CL Item
Bruising (58)
(Comment:en)
CL Item
Alopecia (59)
(Comment:en)
CL Item
Libido loss (60)
(Comment:en)
CL Item
Other (61)
(Comment:en)
Item
Grade
integer
C0877248 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
C1516728 (UMLS CUI [1,3])
Code List
Grade
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
Item
Treatment Relation
integer
C1706735 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Code List
Treatment Relation
CL Item
Unrelated (1)
CL Item
Unlikely (2)
CL Item
Possible (3)
CL Item
Probable (4)
CL Item
Definite (5)
Comment
Item
Notes
text
C0947611 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Item Group
Ccrr Module For S0100 Induction And Consolidation Toxicity Form
C0013221 (UMLS CUI-1)
C0087111 (UMLS CUI-2)
C0023418 (UMLS CUI-3)
Patient ID
Item
SWOG Patient ID
text
C2348585 (UMLS CUI [1])
Study Number
Item
SWOG Study No.
text
C0008976 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Registration Step
Item
Registration Step
text
C1514821 (UMLS CUI-1)
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Institution
Item
Institution/Affiliate
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Treating Physician
Item
Physician
text
C25364 (NCI Thesaurus Property)
C25741 (NCI Thesaurus ObjectClass)
C25705 (NCI Thesaurus ObjectClass-2)
C1710470 (UMLS CUI [1])
Item
Cycle
integer
C0087111 (UMLS CUI [1,1])
C0205390 (UMLS CUI [1,2])
C0023418 (UMLS CUI [2])
Code List
Cycle
CL Item
Current Phase Of Leukemia Treatment For Patient Is Induction (1)
CL Item
Current Phase Of Leukemia Treatment For Patient Is Crossover (2)
CL Item
Current Phase Of Leukemia Treatment For Patient Is Consolidation (3)

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video